Back to company

Boehringer Ingelheim Animal Health Denmark A/S: Financial statements 2024

CVR: 13526990

Boehringer Ingelheim Animal Health Denmark A/S (CVR 13526990) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 634,426,000 and a net result of DKK 40,407,000 compared with DKK 14,503,000 the year before. That is an increase of 8.4% compared with the year before. The profit margin was 6.4%. Equity amounted to DKK 113,624,000. The solvency ratio was 28.1%. The company had 93,000 employees in the financial year.

Revenue
634,426,000 kr.
Gross Profit
151,137,000 kr.
Profit/Loss
40,407,000 kr.
Equity
113,624,000 kr.
Total Assets
404,618,000 kr.
Employees
93,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024634.4 mio.151.1 mio.40.4 mio.113.6 mio.93000
2023585.3 mio.129.9 mio.14.5 mio.98.6 mio.92000
2022587.5 mio.105.3 mio.17.5 mio.94 mio.96
2021588.5 mio.111.4 mio.25 mio.77.1 mio.103
2020622.6 mio.147.7 mio.51.2 mio.98.2 mio.109

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Boehringer Ingelheim Animal Health Denmark A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Niko Rodio leaves the board of Boehringer Ingelheim Animal Health Denmark A/SNov 1, 2024

As of November 1, 2024, Niko Rodio has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Dirk Neven Rauleder joins the board of Boehringer Ingelheim Animal Health Denmark A/SSep 1, 2024

As of September 1, 2024, Dirk Neven Rauleder has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Niels Berenth From leaves the board of Boehringer Ingelheim Animal Health Denmark A/SSep 1, 2024

As of September 1, 2024, Niels Berenth From has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Dirk Neven Rauleder joins Boehringer Ingelheim Animal Health Denmark A/S as adm. dir.Sep 1, 2024

As of September 1, 2024, Dirk Neven Rauleder is registered as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.

Niels Berenth From steps down as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/SSep 1, 2024

As of September 1, 2024, Niels Berenth From has stepped down as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.

Boehringer Ingelheim Animal Health Denmark A/S: The 2023 annual report is outJul 1, 2024

Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2023. Revenue came to DKK 585,336,000, and the net result was DKK 14,503,000.

About Boehringer Ingelheim Animal Health Denmark A/S

Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 95 employees. In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity amounted to DKK 90,111,000.